2023-08-01 06555593 2024-07-31 06555593 2023-08-01 2024-07-31 06555593 2023-07-31 06555593 2022-08-01 2023-07-31 06555593 uk-core:WithinOneYear 2023-07-31 06555593 uk-core:WithinOneYear 2024-07-31 06555593 uk-bus:Director1 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure 06555593 uk-bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 06555593 uk-bus:Micro-entities 2023-08-01 2024-07-31 06555593 uk-bus:FullAccounts 2023-08-01 2024-07-31 06555593 uk-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31
Pharmalink Solutions Limited
Registered Number:06555593
For the year ended 31 July 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 July 2024
Pharmalink Solutions Limited
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
3
06555593
Registered Number :
As at 31 July 2024
Pharmalink Solutions Limited
Statement of Financial Position and Notes to the Accounts
£
£
2023
2024
£
£
1,597
2,130
Fixed assets
404,413
350,199
Current assets
Prepayments and accrued income
2,166
2,166
Creditors: amounts falling due
within one year
(110,305)
(115,729)
242,060
290,850
Net current assets
Total assets less current liabilities
292,447
244,190
-
(92)
Provisions for liabilities
292,447
Net assets
244,098
292,447
244,098
Capital and reserves
Notes to the Accounts
Statutory Information
Pharmalink Solutions Limited is a private limited company, limited by shares, domiciled in England and Wales,
registration number 06555593.
Registered address:
2 Wilsden Road
Harden
Bingley
West Yorkshire
BD16 1JP
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 5 (2023 : 5)
1 of 2
4
06555593
Registered Number :
For the year ended 31 July 2024
Pharmalink Solutions Limited
Statement of Financial Position and Notes to the Accounts Continued
For the year ended 31 July 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mr Shahbab Hussain Director
These financial statements were approved and authorised for issue by the Board on 22 May 2025 and were signed by:
2 of 2